-->
Advertisement

HIV Conferences: A Look Back at 2012
  

Shaking the Status Quo: 2012 HIV/AIDS Conference Research Highlights

November 15, 2012

 5/8 

pills in a stoppered bottle

HIV Treatment Strategy

For a fair amount of time during the 2000s, the debate over when to start antiretroviral therapy was frequently referred to as a "pendulum," as dueling studies stoked the debate over the value of early initiation (to reduce viral load and stave off immune decline) versus its risks (namely, the toxicities of HIV medications and the risks of emergent resistance due to imperfect adherence).

2012 may prove to be the year that the pendulum finally stopped swinging.

A growing number of studies (and the guidelines based on their findings) support HIV treatment initiation at higher and higher CD4+ cell counts. There may be none more important than the landmark HPTN 052 study, which last year stunned the clinical and research communities by revealing a 96% reduction in HIV transmission risk among serodiscordant couples in which the HIV-infected partner initiated treatment early and maintained virologic suppression.

At this year's International AIDS Conference, new HPTN 052 data were unveiled that demonstrated benefits for the HIV-infected partner as well: significant reductions in comorbidities and significantly delayed mortality among those who begin HIV treatment with a CD4+ cell count above 350.

It is findings such as these that make geniuses out of people such as the San Francisco public health officials who instituted a "treat everyone with HIV" policy back in 2010. That program has, of course, been strikingly successful. While antiretroviral therapy should never be prescribed blindly or without taking into account a patient's capability to take medications safely and adhere to them, the reasons to hold off on at least recommending treatment initiation to all patients appear to be dwindling.





This article was provided by TheBodyPRO.com.
 

Reader Comments:

Comment by: Adam (bUAbBcbGM) Wed., Jan. 9, 2013 at 10:39 am EST
It's a pleasure to find someone who can iedntify the issues so clearly
Reply to this comment


Comment by: Solikhul (QkvGZTuGMZoZYmFF) Wed., Jan. 9, 2013 at 10:38 am EST
yes it does, thank you!! I have been experimenting with my 2-strand twsits lately. I sweat a lot in my scalp, so after about 6-7 days I can't take it anymore. I have to wash. I did do a co-wash while the twsits were still in. It came out very nice, and got me though another 3-4 days before I had to completely do a shampoo wash. Thank you so much for your very helpful videos and positive sweet spirit. God Bless!
Reply to this comment


Comment by: Pratik (EbAYdcFtT) Wed., Jan. 9, 2013 at 10:37 am EST
Candida is a type of fungus that grows in your body. It's mcpioscoirc so you don't see it. When too much of it gets in your digestive system, you get permanent rotten breath. Go to any health food store and ask for medicine to do a candida cleanse, and you'll get it. The price is reasonable (anywhere from $10-$40) considering you won't need to buy anywhere near as much gum or tic-tacs for the rest of your life. I used to buy a huge box of tic-tacs to last only two weeks! It was hell.
Reply to this comment


Comment by: Gurbachan S (Ottawa) Wed., Nov. 28, 2012 at 1:39 pm EST
A great summary of the conference and where everything stands as at today.

I think 30 years is too long. I blame part of this on the parochial interest of Corporations and Institutes. If there was high level collaboration this problem could have been easily resolved.

After two years of treatment the laboratory details of the Berlin Man and the other two are still very scanty and not in the public domain.

We need to give hope to the 30 million infected world0wide that we are doing our best.

Best regards
Reply to this comment


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement